We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current ARCT market cap is 419.31M. The company's latest EPS is USD -1.0974 and P/E is -14.11.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 45.14M | 33.99M | 38.01M | 49.86M | 41.67M |
| Operating Income | -18M | -15.14M | -30.41M | -21.13M | -10.74M |
| Net Income | 1.66M | -8.57M | -26.82M | -17.22M | -6.9M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 20.79M | 9.54M | 12.36M | 206M | 166.8M |
| Operating Income | -25.55M | -71.79M | -202.34M | 11.66M | -78.21M |
| Net Income | -25.99M | -72.15M | -203.67M | 9.35M | -29.73M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 457.65M | 429.4M | 418.85M | 388.61M | 370.65M |
| Total Liabilities | 177.59M | 147.76M | 154.88M | 130.03M | 108.79M |
| Total Equity | 280.06M | 281.65M | 263.97M | 258.58M | 261.87M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 82.14M | 476.46M | 392.81M | 450.39M | 429.4M |
| Total Liabilities | 56.35M | 79.9M | 164.6M | 180.08M | 150.89M |
| Total Equity | 25.79M | 396.55M | 228.21M | 270.31M | 278.51M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -17.47M | N/A | -5.56M | -35.7M | -59.46M |
| Investing | -2.03M | N/A | -240k | -568k | -648k |
| Financing | -5.43M | N/A | 2.19M | 4.59M | 5.28M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -6.45M | -42.86M | -135.04M | 31.99M | -18.1M |
| Investing | -818k | -1.74M | -3.41M | -7.73M | -2.9M |
| Financing | 41.91M | 436.15M | 48.02M | -2.86M | -24.09M |
| Market Cap | 419.31M |
| Price to Earnings Ratio | -14.11 |
| Price to Sales Ratio | 2.51 |
| Price to Cash Ratio | 1.44 |
| Price to Book Ratio | 1.51 |
| Dividend Yield | - |
| Shares Outstanding | 27.09M |
| Average Volume (1 week) | 461.48k |
| Average Volume (1 Month) | 381.6k |
| 52 Week Change | -52.68% |
| 52 Week High | 45.00 |
| 52 Week Low | 14.30 |
| Spread (Intraday) | 3.78 (19.61%) |
| Company Name | Arcturus Therapeutics Holdings Inc |
| Address |
10628 science center drive, suite 250 san diego, california 92121 |
| Website | https://arcturusrx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
